Axxcess Wealth Management, LLC Oncternal Therapeutics, Inc. Transaction History

Axxcess Wealth Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.86 - $22.2 $15,050 - $388,500	-17,500 Reduced 19.92%	70,363 $70,000
Q1 2022 Aug 11, 2022	BUY	$1.37 - $2.43 $23,975 - $42,525	17,500 Added 24.87%	87,863 $122,000
Q4 2021 Aug 11, 2022	BUY	$2.27 - $4.39 $159,724 - $308,893	70,363 New	70,363 $160,000

362K

Ticker ONCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,517,200
Market Cap $62.7M
Description
Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a smal...

Get notified when there are updates to the investment portfolio of Axxcess Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Axxcess Wealth Management, LLC with notifications on news.